Navigation Links
MicroRNAs circulating in blood show promise as biomarkers to detect pancreatic cancer
Date:9/4/2009

HOUSTON - A blood test for small molecules abnormally expressed in pancreatic cancer may be a promising route to early detection of the disease, researchers at The University of Texas M. D. Anderson Cancer Center report in the September edition of the journal Cancer Prevention Research.

The team's analysis of four microRNAs (miRNA) found in the blood plasma of pancreatic cancer patients is proof of principle to further develop a blood test for this evasive disease, said senior author Subrata Sen, Ph.D., associate professor in M. D. Anderson's Department of Molecular Pathology.

"Increased expression of microRNAs is known to be involved with specific genetic pathways and processes responsible for the development of cancer-associated changes in cells," Sen said. "Detection of elevated levels of miRNAs in blood plasma of pancreatic cancer patients as informative biomarkers of disease appears to be a promising, novel approach for developing a minimally invasive assay for detecting this disease."

There is no accurate, noninvasive way to detect pancreatic cancer, the fourth-leading cause of cancer-related deaths in the United States. Fewer than 5 percent of patients survive to five years.

MicroRNAs are single-stranded bits of RNA consisting of 18 to 24 nucleotides that regulate the messenger RNA (mRNA) expressed by genes to tell a cell's protein-making machinery what protein to make.

The four targeted microRNAs previously had been associated in varied ways with pancreatic cancer or with precancerous lesions. Expression of the four was analyzed in 28 patients with pancreatic cancer and 19 healthy people.

The four combined markers accurately identified 64 percent (sensitivity) of the pancreatic cancer cases and correctly identified 89 percent of those without disease (specificity). That degree of sensitivity and specificity are good for a pilot study but don't yet rise to the levels required for translation in the clinic, which would require investigating more circulating microRNAs in blood in a larger sample of persons representing different stages of the disease and healthy controls.

The study's small sample size, which compared only the extremes of pancreatic cancer or the complete absence of the disease, is a limitation, but the results justify continued development of this strategy, Sen said.

One of the miRNAs in the study is overexpressed in precursor lesions that can lead to full pancreatic cancer. "The fact that a microRNA reported to be overexpressed in pre-invasive pancreatic cancer could be detected in blood plasma from pancreatic cancer patients raises the possibility that a blood test for detecting pre-invasive pancreatic cancer may become a reality," Sen said.

Marker miRNAs used in the study were miR-21, miR-210, miR-155 and miR-196a.

Sen and colleagues are working with the Early Detection Research Network of the National Cancer Institute to develop studies with larger sample sizes that are designed to test miRNA markers associated with different grades and stages of the disease.


'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Related medicine news :

1. Study in Nature: MicroRNAs hold promise for treating diseases in blood vessels
2. MicroRNAs make for safer cancer treatments
3. Putting microRNAs on the stem cell map
4. MicroRNAs appear essential for retinal health
5. MicroRNAs, EMT and cancer progression
6. Replacing absent microRNAs could make tumors less invasive, more treatable
7. MicroRNAs May Predict Colon Cancer Prognosis
8. 2 microRNAs promote spread of tumor cells
9. MicroRNAs may be key to HIVs ability to hide, evade drugs, Jefferson scientists find
10. Bone from blood: Circulating cells form bone outside the normal skeleton, Penn study finds
11. Levels of Circulating Tumor Cells Could Predict Prostate Cancer Outcome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 2017 , ... Planet Fitness, one of the largest and fastest growing franchisors ... a flagship location in Covington, LA at 401 N. U.S. Highway 190, in January ... Office Depot in the Holiday Square shopping center. Its location allows it to serve ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical ... Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. ... honor of Morris F. Collen, a pioneer in the field of medical informatics, this ...
(Date:10/12/2017)... ... 2017 , ... Dr. Parsa Mohebi, the Los Angeles based ... the newly revamped Cosmetic Town journal section, featuring articles written by ... as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I enjoy ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... On Saturday, ... a treadmill relay – Miles by Moonlight to raise money for the American Heart ... or more. , Teams will work together to keep their treadmills moving for ...
(Date:10/12/2017)... ... , ... In the United States, single-family home owners pay ... York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the average is $7,000 a ... rates, which contributes to the relatively lower cost of living in places like ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017  Eli Lilly and Company (NYSE: ... the third quarter of 2017 on Tuesday, October 24, ... that day with the investment community and media to ... conference call will begin at 9 a.m. Eastern time. ... live webcast of the conference call through a link ...
(Date:9/28/2017)... WASHINGTON , Sept. 28, 2017 Cohen ... to advance the use of wearable and home sensors ... brain disorders. Early Signal Foundation, a nonprofit organization focused ... populations, will provide an affordable analytical system to record ... ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
Breaking Medicine Technology: